Stocktoria
Dermata Therapeutics, Inc. DRMA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-08-13
Dermata Therapeutics, Inc. statistics & valuation
Market cap$5.2M
P / B0.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -96.1% | -347.7% | -97.7% | -138.4% | -68.0% |
| Return on equity | -121.5% | -787.1% | -122.7% | -159.6% | -78.2% |
| Current ratio | — | — | — | — | 7.66 |
Source: SEC EDGAR filings · CIK 0001853816 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.